Our purpose

At PLG, the way we lead, work and behave is driven by our core purpose: improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions.

This purpose influences how we meet client needs while respecting the regulatory requirements of each country in which we operate.

Our Values: #Teamwork & Diversity – #Entrepreneurship mindset – #Customer oriented – #Learn to learn – #Continuous improvement – #Innovation

Your Trusted Partner

Since 1993, ProductLife Group (PLG) has supported clients throughout the life sciences product life cycle, combining local expertise with global reach and spanning more than 150 countries. PLG is a life sciences consulting business that offers outsourced services in the areas of regulatory affairs, quality and compliance, vigilance, and medical information. Our expertise spans oversight of both established products and innovative therapeutics and diagnostics.

PLG is committed to continuously improving the firm’s value through long-term partnerships, innovations, flexibility, and cost-efficiency.

Our Corporate Social Responsibility Charter

Our Corporate Social Responsibility Charter

PLG is committed to being an ethical business. Business ethics build trust with our clients, shareholders, team members, suppliers, and other stakeholders. They provide the right environment and act as a business enabler to support our clients’ ambition and growth.

PLG is committed to comply with all applicable competition and antitrust laws and regulations and rejects any form of bribery and corruption.

In April 2020, PLG has issued, promoted, and supported a Code of Business Ethics. As part of this program, every employee receives the Code of Business Ethics and is expected to comply and follow specific training.

PLG supports and adheres to:

  • The principles of the 1948 Universal Declaration of Human Rights and refuses the use of forced labor and child labor;
  • The principles of the fundamental conventions on labor standards of the International Labour Organization;
  • The OECD Guidelines for Multinational Enterprises;
  • The principles of the UN Global Compact Program and has signed on to the UN Global Compact “Caring for Climate”.

ProductLife Group Sustainability Report outlines our efforts, achievements and future goals in integrating sustainability into our operations. We recognize the importance of Corporate and Social Responsibility, and we consider it as central to our future growth.

As a participant to the UN Global Compact initiative, ProductLife Group supports and integrates its principles in our policies and day-to-day operations.

This report outlines our sustainability approach, environmental initiatives, social initiatives, achievements and future goals. We strive to minimize our environmental impact, promote social responsivity and engage stakeholders to drive positive change.

Our sustainability strategy focuses on three pillars: governance and leadership, environmental stewardship and social responsibility.

Facts and Figures

1300+

Experts worldwide

150

Countries covered

1000

clients worldwide, including 7 of the top 10

99.7%

Of variations managed by PLG received regulatory approval

PLG Advisory Board

The mission of PLG Advisory Board is to help PLG gain insights and advice to address the Company’s strategy & orientations or explore new business opportunities.

Xavier Duburcq

Chief Executive Officer, PLG

• Joined PLG in May 2020
• Background: Pharmacist and Immucologist (PhD)
• >20 years of industry experience (former VP of Altran Life Sciences Business)

Denis Gross

Chief Solutions Officer, PLG

• Joined PLG in September 2018
• Background: Pharmacist (PhD)
• >30 years of industry experience in Regulatory Affairs and Drug Development (Nestlé Skin Health, Galderma, Servier

Frederic Duchesne

Former President and CEO Pharma, Pierre Fabre

• Advisor, Sophia Genetics
• Background: Pharmacist (PhD)
• >20 years of managing experience in various companies (Pierre Fabre, Sanofi, BMS) and now board member in many SMEs

Guillaume Clément

Executive VP Global Business Unit Thrombosis, Leo Pharma

• Joined LeoPharma in November 2009
• Background: Chemistry
• General Manager in various companies (Cephalion, Polepharma)

Julie Lepin

Senior Vice President, Head of Regulatory Affairs, Safety and Quality, Sana Biotechnology

• Joined Sana Biotechnology in 2022
• Background: Biochemistry and Regulatory Affairs
• >20 years as VP and other managing positions in Regulatory Affairs (Galderma, Merck, Amgen)

Patricia Maillere

Former VP, Worldwide RA Advisor, Servier

• Joined Servier in 1984
• Background: Pharmacist (PhD)
• >30 years managing Regulatory Affairs in Servier, now as VP Worldwide

Vincent Vandamme

Senior VP Quality Strategy/Head of Global Quality, Orgenesis Inc.

• Joined Orgenesis in September 2020
• Background: Pharmacist
• >20 years managing Quality in various companies (including GSK, Pfizer)

You can rely on:

You can rely on:

  1. Our experience and expertise in the forms of:
  • Over 600 clients
  • 150 senior experts
  1. Our expertise from strategy to deployment
  1. Innovations
  • Partnering with innovative start-ups
  • A set of Innovative solutions
  1. Our cost-efficiency
  • 5 right shoring platforms
  • The right staffing by the right experts at the right price
  • Hybrid profiles (RA, PV, QA) in small countries
  1. Global partnerships

Our Executive Committee & Operational Committee

Dr. Xavier Duburcq

Chairman and CEO (ExCo)

Candice Bosson

Chief Human Resources Officer (ExCo)

Dr. Denis Gross

Chief Solutions Officer (ExCo)

Charlène Travers-Chevalier

Chief Commercial Officer (ExCo)

Thomas Galvain

Chief of Staff (ExCo)

Emmanuel Riffault

Chief Operations Officer (ExCo)

Christophe Richarme

Chief Financial & Legal Officer (ExCo)

Joanne Sullivan (ExCo)

EVP America

Jean-Luc Taborin, PhD, MBA

Vice-President, Head of Consulting (OpCo)

Jean-Luc Taborin has more than 25 years’ experience on Strategic and Business Transformation projects in operational positions as well as a consultant in Healthcare industry. His areas of functional expertise cover Growth Strategy, M&A and Corporate development, Business transformation, Digital and Operational excellence.
Prior to joining PLG as Head of Consulting, Jean-Luc worked in Deloitte and Roland Berger as Director, then Partner in "Strategy & Operations" and was previously CEO of affiliate, BU Manager and Manufacturing Director in Sanofi, Eurofins Scientific and L’Oreal.
He has conducted many strategic and operational projects for large pharmaceutical companies (Sanofi, Merck & Co, Astra Zeneca, Johnson&Johnson ...), medium-sized compagnies (Servier, Galderma ...) and Biotech (Nanobiotix, Clovis Oncology) in all geographies EU, NA, LAC & APAC
Besides an Engineering degree from Chimie ParisTech (ENSCP - Paris), Jean-Luc followed the Cedep - Executive MBA Program - in INSEAD (Fontainebleau - France).

Fabrice Galzin

Global Head of Marketing (OpCo)

Brian Lihou

DSI General Manager (OpCo)

Dr. Gabrièle Piaton Breda

Research & Innovation Director (OpCo)

Dr. Phil Smith (OpCo)

Head of Regulatory Affairs Services

Dr. Jerome Coupe

Head of Operations Growth (OpCo)

Sophie Daniel

Head of Quality and Process Improvement (OpCo)

Ismael Riazul

Head of Product Compliance (OpCo)

Natashia De Casamassimi

Head of Regulatory Affairs (OpCo)

Michel Lenaerts

IT Director (OpCo)

Prashanth BSB

Director PV & QPPV (OpCo)

Chetan Javia

Line of Business Director, Principal Consultants & SMEs (OpCo)

Surekha Bhatt

Talent Acquisition Manager (OpCo)

Adrien Canonne

Bid Office Director (OpCo)

Soren Winkel

Pharma IT CEO (OpCo)

Peter Emil Iversen

Pharma IT Chief Commercial Officer (OpCo)

Alex Zwiers

Zwiers Regulatory Consultancy CEO (OpCo)

Seng Phomphotath

Client Partner Director (OpCo)

Arundhati Kasbekar (OpCo)

Director – Delivery platforms and General Manager - India

We are able to support clients in all stages of the product lifecycle, from pre-clinical work to post-approval compliance through the review and approval processes and market-entry strategy.

Xavier Duburcq

CEO